Checkpoint Therapeutics wins FDA nod for skin cancer therapy

1 bulan yang lalu

The U.S. Food and Drug Administration (FDA) has approved Checkpoint Therapeutics’ (NASDAQ:CKPT) PD-L1 blocking antibody Unloxcyt cosibelimab-ipdl arsenic a curen for definite patients pinch tegument cancer, cutaneous squamous compartment carcinoma (cSCC).
Accordingly, nan intravenous infusion will beryllium disposable arsenic a late-line